Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Yidu Tech, Inc. ( (HK:2158) ) has issued an update.
Yidu Tech Inc. reported an 8.7% increase in revenue for the six months ending September 2025, driven by favorable industry policies and increased market demand. The company’s strategic focus on core clients and business segments, along with improved operational efficiency, resulted in a significant reduction in operating losses by 71.0% and a 72.0% decrease in overall losses. The company is leveraging its expertise in medical AI to build intelligent systems and infrastructure, positioning itself to capture future market opportunities.
The most recent analyst rating on (HK:2158) stock is a Sell with a HK$4.50 price target. To see the full list of analyst forecasts on Yidu Tech, Inc. stock, see the HK:2158 Stock Forecast page.
More about Yidu Tech, Inc.
Yidu Tech Inc. operates in the medical intelligence industry, focusing on integrating artificial intelligence into healthcare, pharmaceuticals, insurance, and patient services. The company aims to enhance the efficiency of medical resources and support comprehensive health management through its ecosystem.
Average Trading Volume: 12,163,979
Technical Sentiment Signal: Sell
Current Market Cap: HK$4.74B
For detailed information about 2158 stock, go to TipRanks’ Stock Analysis page.